Literature DB >> 19758602

The pathophysiological basis of sensory disturbances in Parkinson's disease.

Carlos Juri1, MariCruz Rodriguez-Oroz, Jose A Obeso.   

Abstract

The diagnosis of Parkinson's disease (PD) is still based on the recognition of the cardinal motor features. However, it is now recognized that non-motor manifestations (NMM) may actually precede the emergence of motor manifestations. NMM are very frequently present in the overall population of PD patients and are a major determinant of their quality of life. In this article we discuss the origin of sensory manifestations in PD, particularly focus on pain mechanisms, which is the most frequent and better studied NMM. Analysis of experimental and clinical data reveals that the basal ganglia (BG) indeed have an anatomo-functional organization which sustains sensory functions. In addition, the dopaminergic system is also engaged in the modulation and integration of sensory information and the response to pain. In patients with PD, pain is often related with motor fluctuations and dyskinesias induced by dopaminergic treatments, which suggest some common mechanisms with the origin of motor complications in PD. Clinically, sensory manifestations are often disturbing and poorly treated and may occasionally become a major cause of disability for PD patients. Thus, more clinical and basic studies are warranted to clarify pain mechanisms in PD, with the aim of achieving better treatments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758602     DOI: 10.1016/j.jns.2009.08.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  23 in total

Review 1.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

Review 2.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

3.  Somatosensory symptoms in unmedicated de novo patients with idiopathic Parkinson's disease.

Authors:  Katharina A Schindlbeck; Arne Mehl; Sarah Geffe; Steffen Benik; Serdar Tütüncü; Fabian Klostermann; Frank Marzinzik
Journal:  J Neural Transm (Vienna)       Date:  2015-09-21       Impact factor: 3.575

Review 4.  Management of pain in Parkinson's disease.

Authors:  Munazza Sophie; Blair Ford
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

Review 5.  Integrated Approach for Pain Management in Parkinson Disease.

Authors:  Christian Geroin; Marialuisa Gandolfi; Veronica Bruno; Nicola Smania; Michele Tinazzi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 6.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

7.  Altered brain activation and connectivity in early Parkinson disease tactile perception.

Authors:  H Cao; X Xu; Y Zhao; D Long; M Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-13       Impact factor: 3.825

8.  Is there room for new non-dopaminergic treatments in Parkinson's disease?

Authors:  Manuela Pilleri; Konstantinos Koutsikos; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2012-12-11       Impact factor: 3.575

9.  Deep brain stimulation in Parkinson's disease: motor effects relative to the MRI-defined STN.

Authors:  Juergen Ralf Schlaier; Christine Hanson; Annette Janzen; Claudia Fellner; Andreas Hochreiter; Martin Proescholdt; Alexander Brawanski; Max Lange
Journal:  Neurosurg Rev       Date:  2014-02-28       Impact factor: 3.042

10.  Reaching to proprioceptively defined targets in Parkinson's disease: effects of deep brain stimulation therapy.

Authors:  D Lee; D Y Henriques; J Snider; D Song; H Poizner
Journal:  Neuroscience       Date:  2013-04-13       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.